Atomo Diagnostics Limited Expands Executive Team

April 25 2022

An article from MarketScreener regarding Atomo Diagnostics Limited expanding its executive team


Read the article here


Atomo Diagnostics Limited Expands Executive Team

Atomo Diagnostics Limited announced the expansion and strengthening of its executive commercial team and a change in the COO role to better support renewed international commercial focus and operations activity, the role now being headquartered in Sydney.


Key elements include: Based in San Diego, California, Jim McMenamy joins Atomo as Head of Business Development and Partnerships, the Americas Based in the UK, Anna Tucker joins Atomo as Head of Business Development and Partnerships, Europe, Middle East and Africa (EMEA) Based in Sydney, Chandra Sukumar assumes the role of COO, building on her experience running product development and OEM product management with the company. UK based Mark Smith is departing as Atomo’s COO and transitioning to a consulting role during a transition period.


Jim McMenamy has over 30 years of experience in the global POC diagnostics market having had roles with companies such as Becton Dickinson, Quidel Corp, ACON Laboratories, Inverness Medical, AGEN Biomedical, Samsung Diagnostics and Henry Schein Animal Health. Jim has held leadership roles in areas of Marketing, Sales, Business Development and General Management in global human and veterinary POC diagnostics markets for these organisations.


Anna Tucker brings to Atomo a proven track record of developing businesses across the Life Sciences sector, with more than 25 years’ experience working in sales, distribution management and field marketing globally. As Director, Distributor Sales, EMEA at Congenica, Anna was responsible for driving revenue growth through the identification, selection and ongoing management of a network of distributors and expanding the commercial footprint of Congenica’s diagnostic software and services business across EMEA.


The promotion of Chandra Sukumar into the role of COO enables operational leadership to be based at Atomo’s global headquarter based in Sydney. It also leverages her successful leadership directing Atomo’s development programs for key platform programs such as Elion and our new integrated swab device (Blackburn), as well as her management of both technical and product support for Atomo’s OEM customers, which is key as Atomo expands its market presence.